We study the price level of pharmaceuticals in Sweden relative to the following nine European countries; Austria, Belgium, Denmark, Finland, Germany, Ireland, the Netherlands, Norway, and United Kingdom (UK). Our sample consists of prescription drugs that do not have generic sale in Sweden. Using IMS Health data on prices and sales volumes for the first half of 2010, we compute several price indices to describe the price differences and potential cost savings in the non-generic market segment. Our results show that the Swedish price level is slightly below average relative to the other European countries. UK, Norway and the Netherlands tend to have lower prices than Sweden, whereas Germany, Ireland and Denmark tend to have higher prices. Fi...
Objectives To compare prices of new drugs between France and the other EU4. Methods Study use...
AIM: The study aims to analyse Austrian prices of high-cost medicines in comparison to other Europea...
This study is aimed at analyzing the effectiveness of state intervention in the form of pharmaceutic...
We study the price level of pharmaceuticals in Sweden relative to the following nine European countr...
In this report we compare prices of pharmaceuticals between Norway and the following nine Western Eu...
In this report we compare prices of pharmaceuticals between Norway and the following nine Western Eu...
In this report we compare prices of pharmaceuticals between Norway and the following nine Western Eu...
In this report we compare prices of pharmaceuticals between Norway and nine Western European countri...
Background: In recent years, high-cost medicines have increasingly been challenging the public healt...
<p><b>Background</b>: In recent years, high-cost medicines have increasingly been challenging the pu...
The thesis sets out to evaluate price differences on the Nordic market for non-patent covered pain r...
Abstract Background Policymakers and researchers frequently compare the prices of medicines between ...
AbstractObjectiveTo compare prices of medicines, both originators and generics, in New Zealand and 1...
International audienceObjectivesTo compare prices of new drugs between France and the other EU4.Meth...
Background and Objective: This study assessed price differences by comparing annual treatment costs ...
Objectives To compare prices of new drugs between France and the other EU4. Methods Study use...
AIM: The study aims to analyse Austrian prices of high-cost medicines in comparison to other Europea...
This study is aimed at analyzing the effectiveness of state intervention in the form of pharmaceutic...
We study the price level of pharmaceuticals in Sweden relative to the following nine European countr...
In this report we compare prices of pharmaceuticals between Norway and the following nine Western Eu...
In this report we compare prices of pharmaceuticals between Norway and the following nine Western Eu...
In this report we compare prices of pharmaceuticals between Norway and the following nine Western Eu...
In this report we compare prices of pharmaceuticals between Norway and nine Western European countri...
Background: In recent years, high-cost medicines have increasingly been challenging the public healt...
<p><b>Background</b>: In recent years, high-cost medicines have increasingly been challenging the pu...
The thesis sets out to evaluate price differences on the Nordic market for non-patent covered pain r...
Abstract Background Policymakers and researchers frequently compare the prices of medicines between ...
AbstractObjectiveTo compare prices of medicines, both originators and generics, in New Zealand and 1...
International audienceObjectivesTo compare prices of new drugs between France and the other EU4.Meth...
Background and Objective: This study assessed price differences by comparing annual treatment costs ...
Objectives To compare prices of new drugs between France and the other EU4. Methods Study use...
AIM: The study aims to analyse Austrian prices of high-cost medicines in comparison to other Europea...
This study is aimed at analyzing the effectiveness of state intervention in the form of pharmaceutic...